Invo Bioscience Stock Return On Equity
| INVODelisted Stock | USD 0.84 0.03 3.45% |
INVO Bioscience fundamentals help investors to digest information that contributes to INVO Bioscience's financial success or failures. It also enables traders to predict the movement of INVO Stock. The fundamental analysis module provides a way to measure INVO Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INVO Bioscience stock.
INVO |
INVO Bioscience Company Return On Equity Analysis
INVO Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current INVO Bioscience Return On Equity | -143.59 |
Most of INVO Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, INVO Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, INVO Bioscience has a Return On Equity of -143.5864. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
INVO Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses INVO Bioscience's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of INVO Bioscience could also be used in its relative valuation, which is a method of valuing INVO Bioscience by comparing valuation metrics of similar companies.INVO Bioscience is currently under evaluation in return on equity category among its peers.
INVO Fundamentals
| Return On Equity | -143.59 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (1.04) % | |||
| Current Valuation | 15.19 M | |||
| Shares Outstanding | 3.91 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Number Of Shares Shorted | 1.95 K | |||
| Price To Book | 5.97 X | |||
| Price To Sales | 0.56 X | |||
| Revenue | 3.02 M | |||
| Gross Profit | 535.27 K | |||
| EBITDA | (6.63 M) | |||
| Net Income | (8.03 M) | |||
| Cash And Equivalents | 1.96 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 8.68 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 1.99 X | |||
| Book Value Per Share | (1.59) X | |||
| Cash Flow From Operations | (4.76 M) | |||
| Short Ratio | 0.04 X | |||
| Earnings Per Share | 0.69 X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 25 | |||
| Beta | 1.44 | |||
| Market Capitalization | 3.25 M | |||
| Total Asset | 20.89 M | |||
| Retained Earnings | (57.82 M) | |||
| Working Capital | (6.96 M) | |||
| Net Asset | 20.89 M |
About INVO Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INVO Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INVO Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INVO Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with INVO Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INVO Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving against INVO Stock
| 0.78 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.53 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.45 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.38 | HYMTF | Hyundai Motor | PairCorr |
| 0.34 | TLK | Telkom Indonesia Tbk | PairCorr |
The ability to find closely correlated positions to INVO Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INVO Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INVO Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INVO Bioscience to buy it.
The correlation of INVO Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INVO Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INVO Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INVO Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in INVO Stock
If you are still planning to invest in INVO Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the INVO Bioscience's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |